The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Prevalence and Healthcare Actions of Women in a Large Health System with a Family History Meeting the 2005 USPSTF Recommendation for BRCA Genetic Counseling Referral
Abstract
Background: In 2005, the United States Preventive Services Task Force (USPSTF) released guidelines which outlined specific family history patterns associated with an increased risk for BRCA1/2 mutations, and recommended at-risk individuals be referred for genetic counseling and evaluation for BRCA testing. The purpose of this study was to assess the prevalence of individuals with a USPSTF increased-risk family history pattern, the frequency with which specific patterns were met, and resulting healthcare actions among women from the Henry Ford Health System. Methods: As part of a study evaluating ovarian cancer risk perception and screening, 2,524 randomly selected participants completed a detailed interview (response rate 76%) from an initial eligible cohort of 16,720 women. Results: Approximately 6% of participants had a family history fulfilling one or more of the USPSTF patterns. Although 90% of these women had shared their family history with their provider, less than 20% had been referred for genetic counseling and only 8% had undergone genetic testing. Caucasian women with higher income and education levels were more likely to receive referrals. Among the 95 participants in the total study cohort who reported BRCA testing, 78% did not have a family history that met one of the USPSTF patterns. Conclusions: These results suggest a higher prevalence of women with an increased-risk family history than originally predicted by the USPSTF, and lack of provider recognition and referral for genetic services. Impact: Improvements in healthcare infrastructure and clinician education will be required to realize population level benefits from BRCA genetic counseling and testing. Cancer Epidemiol Biomarkers Prev; 22(4); 728–35. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the USPSTF recommendation and the increasing availability of genetic testing for hereditary cancer syndromes, many women who are at an increased risk of carrying BRCA1/2 mutations are never identified and are thus unable to receive downstream preventive services [22–25].”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [22]
In the citing paper
“While the prevalence of BRCA1/2 mutations is similar across most racial and ethnic groups (except Ashkenazi Jews), women from racial/ethnic minority groups and lower education and income levels are less likely to be referred for genetic testing [22, 27, 28].”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [22]
In the citing paper
“Although 91% of these high-risk women reported that they had talked to their health care provider about their family history, only 14% were referred for genetic counseling, and only 4% received BRCA1/2 genetic testing.”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [22]
In the citing paper
“In a large sample of women unaffected with breast cancer seen in the primary care setting, 5% met USPSTF guidelines for genetic counseling.”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [22]
In the citing paper
“Although 91% of these high-risk women reported that they had talked to their health care provider about their family history, only 14% were referred for genetic counseling, and only 4% received BRCA1/2 genetic testing.”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [22]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802 · cited 1×
“Women with BRCA1/2 mutations face lifetime risks for breast and ovarian cancer of approximately 40% to 60% and 20% to 40%, respectively (5).”
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn442 · Cited by 939
Research works printed but not linked: 32
- Anglian Breast Cancer Study Group, 2000, Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases, Br J Cancer, 83, 1301, 10.1054/bjoc.2000.1407 · DOI · Paper page
- Risch, 2006, Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada, J Natl Cancer Inst, 98, 1694, 10.1093/jnci/djj465 · DOI · Paper page
- Pal, 2005, BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases, Cancer, 104, 2807, 10.1002/cncr.21536 · DOI · Paper page
- Nelson, 2005, Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services USPSTF, Ann Intern Med, 143, 362, 10.7326/0003-4819-143-5-200509060-00012 · DOI · Paper page
- Isern, 2008, Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer, Eur J Surg Oncol, 34, 1148, 10.1016/j.ejso.2008.03.002 · DOI
- Kauff, 2008, Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study, J Clin Oncol, 26, 1331, 10.1200/JCO.2007.13.9626 · DOI · Paper page
- Saslow, 2007, American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography, CA Cancer J Clin, 57, 75, 10.3322/canjclin.57.2.75 · DOI · Paper page
- Kurian, 2010, Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers, J Clin Oncol, 28, 222, 10.1200/JCO.2009.22.7991 · DOI · Paper page
- Warner, 2011, Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging, J Clin Oncol, 29, 1664, 10.1200/JCO.2009.27.0835 · DOI · Paper page
- Kaas, 2010, Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer, Ann Surg, 251, 488, 10.1097/SLA.0b013e3181c3c36d · DOI
- Domchek, 2006, Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study, Lancet Oncol, 7, 223, 10.1016/S1470-2045(06)70585-X · DOI · Paper page
- Warner, 2008, Systematic review: using magnetic resonance imaging to screen women at high-risk for breast cancer, Ann Intern Med, 148, 671, 10.7326/0003-4819-148-9-200805060-00007 · DOI · Paper page
- United States Preventive Services Task Force, 2005, Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement, Ann Intern Med, 143, 355, 10.7326/0003-4819-143-5-200509060-00011 · DOI · Paper page
- Levy, 2009, Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization, J Gen Intern Med, 24, 822, 10.1007/s11606-009-1009-6 · DOI · Paper page
- Hall, 2008, Population prevalence of first-degree family history of breast and ovarian cancer in the United States: Implications for genetic testing, Open Health Serv Policy J, 1, 38
- Palomaki, 2006, Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women, Genet Med, 8, 161, 10.1097/01.gim.0000204458.84988.f2 · doi:10.1097/01.gim.0000204458.84988.f2
- McClain, 2008, Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women, Fam Cancer, 7, 341, 10.1007/s10689-008-9188-6 · doi:10.1007/s10689-008-9188-6
- Johnson, 2005, Genomics–the perfect information-seeking research problem, J Health Commun, 10, 323, 10.1080/10810730590950048 · DOI
- Bellcross, 2011, Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians, Am J Prev Med, 40, 61, 10.1016/j.amepre.2010.09.027 · DOI · Paper page
- Trivers, 2011, Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study, Cancer, 117, 5334, 10.1002/cncr.26166 · DOI · Paper page
- Petrucelli, 2010, Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2, Genet Med, 12, 245, 10.1097/GIM.0b013e3181d38f2f · DOI · Paper page
- Steiner, 2008, Assessing breast cancer risk in women, Am Fam Phys, 78, 1361
- Irshad, 2011, Therapeutic potential of PARP inhibitors for metastatic breast cancer, Expert Rev Anticancer Ther, 11, 1243, 10.1586/era.11.52 · DOI
- ACOG Committee on Practice Bulletins, 2009, Hereditary breast and ovarian cancer syndrome, Gynecol Oncol, 113, 6, 10.1016/j.ygyno.2009.02.017 · DOI
- Katapodi, 2004, Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review, Prev Med, 38, 388, 10.1016/j.ypmed.2003.11.012 · DOI · Paper page
- Dancyger, 2011, Communicating BRCA1/2 genetic test results within the family: a qualitative analysis, Psychol Health, 26, 1018, 10.1080/08870446.2010.525640 · DOI
- Kenen, 2004, We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC), Psychooncology, 13, 335, 10.1002/pon.745 · DOI
- Koehly, 2009, Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions, Am J Public Health, 99, 2203, 10.2105/AJPH.2008.154096 · DOI
- Mai, 2011, Confirmation of family cancer history reported in a population-based survey, J Natl Cancer Inst, 103, 788, 10.1093/jnci/djr114 · DOI
- Murff, 2004, Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history, JAMA, 292, 1480, 10.1001/jama.292.12.1480 · DOI · Paper page
- Ziogas, 2003, Validation of family history data in cancer family registries, Am J Prev Med, 24, 190, 10.1016/S0749-3797(02)00593-7 · DOI · Paper page
- 2011, Cancer survivors–United States, 2007, MMWR Morb Mortal Wkly Rep, 60, 269
Cited by
Silverman, T. B., Vanegas, A., Marte, A., Mata, J., Sin, M., Ramirez, J. C. R., Tsai, W.-Y., Crew, K. D., & Kukafka, R. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3442-x · Cited by 19
Metadata
- Authors
- Bellcross, C. A., Leadbetter, S., Alford, S. H., & Peipins, L. A.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2013-04-01
- Volume
- 22
- Issue
- 4
- Pages
- 728-735
- ISSN
- 1055-9965
- 1538-7755
- Cited by
- 47
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Healthcare Actions of Women in a Large Health System with a Family History Meeting the 2005 USPSTF Recommendation for BRCA Genetic Counseling Referral. https://app.cochat.ai/papers/10.1158/1055-9965.epi-12-1280
- The paper
- Bellcross, C. A., Leadbetter, S., Alford, S. H., & Peipins, L. A. (2013). Prevalence and Healthcare Actions of Women in a Large Health System with a Family History Meeting the 2005 USPSTF Recommendation for BRCA Genetic Counseling Referral. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-12-1280
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.